Results 101 to 110 of about 5,178 (152)

Tanshinone I induces apoptosis and protective autophagy in human glioblastoma cells via a reactive oxygen species‑dependent pathway. [PDF]

Int J Mol Med, 2020
Jian S, Chen L, Minxue L, Hongmin C, Ronghua T, Xiaoxuan F, Binbin Z, Shiwen G.   +7 more
europepmc   +1 more source

Evaluation of the Role of Tanshinone I in an In Vitro System of Charcot-Marie-Tooth Disease Type 2N. [PDF]

Int J Mol Sci
Zhang J, Meng X, Qin Q, Liang Y, Yang G, Li S, Li X, Zhou JC, Sun L.   +8 more
europepmc   +1 more source

Anti-Obesity Effects of Tanshinone I from Salvia miltiorrhiza Bunge in Mice Fed a High-Fat Diet through Inhibition of Early Adipogenesis. [PDF]

Nutrients, 2020
Jung DY, Kim JH, Jung MH.
europepmc   +1 more source

Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression. [PDF]

Mol Med Rep, 2021
Zhang Y, Huang J, Huang Y, Zhang S, Wu W, Long H, Duan X, Lai Y, Wu W.   +8 more
europepmc   +1 more source

Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway. [PDF]

J Cell Mol Med, 2019
Wang W, Li J, Ding Z, Li Y, Wang J, Chen S, Miao J.   +6 more
europepmc   +1 more source

Tanshinone I Inhibits IL-1β-Induced Apoptosis, Inflammation And Extracellular Matrix Degradation In Chondrocytes CHON-001 Cells And Attenuates Murine Osteoarthritis. [PDF]

Drug Des Devel Ther, 2019
Wang X, Fan J, Ding X, Sun Y, Cui Z, Liu W.   +5 more
europepmc   +1 more source

RETRACTION: Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. [PDF]

Cell Prolif
europepmc   +1 more source

Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.

Cell Prolif, 2020
Zhou J, Jiang YY, Chen H, Wu YC, Zhang L.   +4 more
europepmc   +1 more source

Tanshinone IIA prevents septicemia acute kidney injury via regulating the DUSP10/JNK/P38/NLRP3 pathway. [PDF]

Am J Transl Res
Wen D, Deng Q, Zeng Y, Li L, Yang X, Chen Q, Yan Y, Lv J.   +7 more
europepmc   +1 more source

Dihydrotanshinone as a Natural Product-Based CYP17A1 Lyase Inhibitor for Hyperandrogenic Disorders. [PDF]

Biomolecules
Li K, Yakubu J, Jørgensen FS, Pandey AV.   +3 more
europepmc   +1 more source